000168688 001__ 168688
000168688 005__ 20240229133612.0
000168688 0247_ $$2doi$$a10.3390/nu13051408
000168688 0247_ $$2pmid$$apmid:33922032
000168688 0247_ $$2altmetric$$aaltmetric:104478785
000168688 037__ $$aDKFZ-2021-00996
000168688 041__ $$aEnglish
000168688 082__ $$a610
000168688 1001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b0$$eFirst author$$udkfz
000168688 245__ $$aPrevention of Advanced Cancer by Vitamin D3 Supplementation: Interaction by Body Mass Index Revisited.
000168688 260__ $$aBasel$$bMDPI$$c2021
000168688 3367_ $$2DRIVER$$aarticle
000168688 3367_ $$2DataCite$$aOutput Types/Journal article
000168688 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1620224222_3861
000168688 3367_ $$2BibTeX$$aARTICLE
000168688 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168688 3367_ $$00$$2EndNote$$aJournal Article
000168688 500__ $$a#EA:C070#LA:C070#
000168688 520__ $$aMeta-analyses of randomized controlled trials (RCTs) have demonstrated a protective effect of vitamin D3 (cholecalciferol) supplementation against cancer mortality. In the VITAL study, a RCT including 25,871 men ≥ 50 years and women ≥ 55 years, protective effects of vitamin D3 supplementation (2000 IU/day over a median of 5.3 years) with respect to incidence of any cancer and of advanced cancer (metastatic cancer or cancer death) were seen for normal-weight participants but not for overweight or obese participants. We aimed to explore potential reasons for this apparent variation of vitamin D effects by body mass index. We conducted complementary analyses of published data from the VITAL study on the association of body weight with cancer outcomes, stratified by vitamin D3 supplementation. Significantly increased risks of any cancer and of advanced cancer were seen among normal-weight participants compared to obese participants in the control group (relative risk (RR), 1.27; 95% confidence interval (CI), 1.07-1.52, and RR, 1.44; 95% CI, 1.04-1.97, respectively). No such patterns were seen in the intervention group. Among those with incident cancer, vitamin D3 supplementation was associated with a significantly reduced risk of advanced cancer (RR, 0.86; 95% CI, 0.74-0.99). The observed patterns point to pre-diagnostic weight loss of cancer patients and preventive effects of vitamin D3 supplementation from cancer progression as plausible explanations for the body mass index (BMI)-intervention interactions. Further research, including RCTs more comprehensively exploring the potential of adjuvant vitamin D therapy for cancer patients, should be pursued with priority.
000168688 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000168688 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000168688 650_7 $$2Other$$abody mass index
000168688 650_7 $$2Other$$acancer
000168688 650_7 $$2Other$$aprevention
000168688 650_7 $$2Other$$asupplementation
000168688 650_7 $$2Other$$avitamin D
000168688 7001_ $$0P:(DE-He78)a1d1b323625dcfa155b477a646cbda52$$aKuznia, Sabine$$b1$$udkfz
000168688 7001_ $$0P:(DE-He78)358cd16fe1dd16be6e4eaf0e76e5ad57$$aLaetsch, Clarissa$$b2$$udkfz
000168688 7001_ $$0P:(DE-He78)20dc4ad11ff465acf5b99f1e679e10b7$$aNiedermaier, Tobias$$b3$$udkfz
000168688 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b4$$eLast author$$udkfz
000168688 773__ $$0PERI:(DE-600)2518386-2$$a10.3390/nu13051408$$gVol. 13, no. 5, p. 1408 -$$n5$$p1408$$tNutrients$$v13$$x2072-6643$$y2021
000168688 909CO $$ooai:inrepo02.dkfz.de:168688$$pVDB
000168688 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000168688 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1d1b323625dcfa155b477a646cbda52$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000168688 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)358cd16fe1dd16be6e4eaf0e76e5ad57$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000168688 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)20dc4ad11ff465acf5b99f1e679e10b7$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000168688 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000168688 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000168688 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000168688 9141_ $$y2021
000168688 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNUTRIENTS : 2018$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-08-29
000168688 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-29
000168688 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-08-29
000168688 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000168688 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000168688 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000168688 980__ $$ajournal
000168688 980__ $$aVDB
000168688 980__ $$aI:(DE-He78)C070-20160331
000168688 980__ $$aI:(DE-He78)C120-20160331
000168688 980__ $$aI:(DE-He78)HD01-20160331
000168688 980__ $$aUNRESTRICTED